1. A. If a patient to whom a licensee administers a pharmaceutical agent experiences an anaphylactic reaction, the licensee may, as provided by A.R.S. § 32-1706(F), use injectable epinephrine to counteract the anaphylactic reaction.

2. B. A licensee who maintains injectable epinephrine at the licensee's practice location shall also maintain the following medically necessary supportive equipment and supplies:

   1. 1. Diphenhydramine in injectable, capsule or tablet, and syrup forms;
   2. 2. Syringes for injecting diphenhydramine;
   3. 3. Wristwatch with a second hand;
   4. 4. Sphygmomanometer with both adult and extra-large cuffs;
   5. 5. Stethoscope;
   6. 6. Adult-size pocket mask with one-way valve;
   7. 7. Tongue depressors; and
   8. 8. Telephone.

Historical Note

Section R4-21-308 renumbered from R4-21-307 and amended effective November 5, 1998 (Supp. 98-4). Amended by final rulemaking at 11 A.A.R. 1864, effective May 3, 2005 (Supp. 05-2). Former R4-21-308 renumbered to R4-21-309; new R4-21-308 made by final rulemaking at 14 A.A.R. 12, effective February 2, 2008 (Supp. 07-4). Amended by final rulemaking at 22 A.A.R. 328, effective March 28, 2016 (Supp. 16-1).